Summer 2025
Preview: New Modalities
Topics to be covered in this special feature:
- AI/ML-guided antibody selection
- enhancing target selectivity
- predicting ADEs such as CRS, ADCs, TCEs, bispecific antibodies
- structural genomics/AI
- CRISPR/Base editing
- display technologies
- affinity modulation of antibodies
- probody engineering
- TME-selective activation of modalities
- multispecific modalities
- tactics to improve the therapeutic index of new modalities
- automated GMP-compliant manufacturing
- allogenic gene/cell therapies
Interested in advertising with us? We’re happy to advise you!
Christian Böhm
+49-30-264921-49
c.boehm@biocom
Oliver Schnell
+49-30-264921-45
o.schnell@biocom.de
Andreas Macht
+49-30-264921-54
a.macht@biocom.de